October 25, 2022, 2022 APP Pharmacology Series presented by MGH and BWH APP Education Committees 2022-2023: Hypertension Management and Medication Considerations - Archived
Description
This activity provides on-demand archived lectures from the APP Pharmacology Series presented by MGH and BWH APP Education Committees 2022-2023. The educational series is designed to provide clinical content that is relevant to multiple disciplines throughout the Mass General Brigham organization. The lectures are designed to provide concise and accurate information that clinicians can use to provide evidence-based care. The lectures have been designed based on feedback from community members.
Course Directors:
Erin Schroeder, NP & Ariel Nowicki, PA-C
For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at partnerscpd@partners.org.
You may print individual certificates throughout the year; your cumulative list of completed activities is accessible on your transcript.
Target Audience
This activity is intended for all APPs, MDs, Pharmacists within Mass General Brigham.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Describe the Public Health Problems of Pain and Inappropriate Opioid Use in America
- List 3 Examples of Best Practices Related to Opioid-Sparing, Multimodal Therapy
- Distinguish the Indications, Benefits and Risks of 3 Drug Classes Used For Pain
Additional Information
Provided by Mass General Brigham
Course Directors
Erin Schroeder, CNP
Nurse Practitioner, Gynecologic Oncology,
Massachusetts General Hospital
Ariel Nowicki, PA-C
Neurosurgery ICU Physician Assistant,
Brigham and Women's Hospital
Faculty
Dareen Kanaan, PharmD, MPH, BCCP
Pharmacist,
Brigham and Women's Hospital
DISCLOSURE SUMMARY OF RELEVANT FINANCIAL RELATIONSHIPS
INELIGIBLE COMPANIES
Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Examples of such organizations include:
- Advertising, marketing, or communication firms whose clients are ineligible companies
- Bio-medical startups that have begun a governmental regulatory approval process
- Compounding pharmacies that manufacture proprietary compounds
- Device manufacturers or distributors
- Diagnostic labs that sell proprietary products
- Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
- Manufacturers of health-related wearable products
- Pharmaceutical companies or distributors
- Pharmacy benefit managers
- Reagent manufacturers or sellers
For more information: https://accme.org/faq/what-accmes-definition-ineligible-company
MITIGATION STRATEGIES
Mass General Brigham has implemented a process to mitigate relevant financial relationships for this continuing education (CE) activity to help ensure content objectivity, independence,
fair balance and ensure that the content is aligned with the interest of the public.
The following planners reported no relevant financial relationship with an ineligible company:
Saksham Gupta, MD
Lindsay Harris, NP
Jessica L Logsdon, PA-C, MHA
Colleen McGauley, NP
Ariel Nowicki, PA-C
Joseph Parseghian, PA-C
Patricia Riley, NP
Darlene Sawicki, NP
Erin Schroeder, NP
Michael Schontz, PharmD, BCPS, BCCCP
The following speaker reported no relevant financial relationship with an ineligible company:
Dareen Kanaan, PharmD, MPH, BCCP
ACCREDITATION
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditTM
Mass General Brigham designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy
This activity provides 1 contact hours (1 CEUs) of continuing education credit. ACPE Universal Activity Number (UAN): JA0007437-0000-22-005-H04-P.
This offering carries 1.0 Pharmacotherapeutic contact hours
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
- 1.00 Contact hours (CEUs) of Continuing Education Credit for Pharmacists